PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsaltitude sickness
MeSH D000532 - altitude sickness
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012120:Respiration disorders
$
Success rate
D000532: 
Altitude sickness
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAcetazolamide Diamox  1982-01-01   
Novast LaboratoriesAcetazolamide Acetazolamide  2016-09-30   
Taro PharmaceuticalAcetazolamide Acetazolamide  1997-05-28   
MylanAcetazolamide Acetazolamide  2012-05-09   
Rising PharmaceuticalsAcetazolamide Acetazolamide  2019-06-18   
Zydus TherapeuticsAcetazolamide Acetazolamide  2019-01-16   
Sun Pharmaceutical IndustriesAcetazolamide Acetazolamide  1988-06-22   
Alembic PharmaceuticalsAcetazolamide Acetazolamide  2019-02-19   
Breckenridge PharmaceuticalAcetazolamide Acetazolamide  2020-04-30   
HospiraAcetazolamide Acetazolamide  1995-10-30   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
86%
12/14
Phase 2
67%
2/3
Phase 3
27%
3/11
Approved: 1Overall Success rate: 16%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use